Ligand Pharmaceuticals
Price & Volume
Stats
See more52W Range | $93.58-$212.49 |
Market Cap | $4B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $251.2M |
Revenue Growth (YoY) | 122.8% |
Gross Profit (12 Mos) | $154.7M |
Diluted EPS | $2.27 |
News
See moreYahoo Finance • last month
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Yahoo Finance • 2 months ago
What Makes Ligand Pharmaceuticals (LGND) an Investment Choice?
Yahoo Finance • 2 months ago
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Yahoo Finance • 2 months ago
Pelthos acquires US rights to Xepi cream from Biofrontera and Ferrer
About
CEO | Mr. Todd C. Davis Ph.D. |
Address | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |
